fibrogen.com (FGEN) Company Sales Revenue

The efficiency of FibroGen, Inc. (FGEN) is confirmed by revenues from the sale of approved drugs through global partners. This revenue chart clearly demonstrates the dynamics of these inflows, where the 0.01 level serves as a critical mark. Fundamentals are strengthening through the expansion of the oncology pipeline via B2B licensing, as well as the implementation of software robots for accelerated clinical trial data processing.

FGEN (FibroGen, Inc.) Revenue and Sales Volume history from 07/04/2022 to 01/08/2026

Analytical breakdowns for FibroGen, Inc.

- market price and analyst price targets:

Market Price FibroGen Corporation|FGEN - Price Target Chart

- market capitalization details:

Market Value FibroGen, Inc.|FGEN - Enterprise Value

- balance sheet net asset value indicators:

Share Book Value FibroGen|FGEN - Book Capitalization|Market Capitalization to Book Value fibrogen.com|FGEN - Company Total Assets

- debt and solvency information:

- net income and valuation multiples indicators:

FGEN - Company Net Income|Net Profit Forecast FibroGen, Inc.|FGEN - Price to Earnings Ratio|Future Price to Earnings Multiple fibrogen.com|FGEN - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio FibroGen, Inc.|FGEN - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months FibroGen|FGEN - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months fibrogen.com|FGEN - Net earnings per share growth this year|Consensus forecast of earnings per share growth for next year FibroGen, Inc.

- company sales and revenue statistics:

FGEN - Revenue and Sales Volume|Company Expected Revenue FibroGen Corporation|FGEN - P/S Multiple|Projected Price to Revenue FibroGen, Inc.

Comprehensive company analysis:FGEN (FibroGen Corporation)

FibroGen, Inc. (FGEN) portfolio diversification across oncology and fibrosis allows the company to smooth operating income volatility. This indicator captures daily revenue volume, reflecting the actual cash inflow from drug sales. Analyzing the dynamics of these inflows helps determine the business's financial stability and prevents overpaying for the asset during periods of market turbulence. The assessment of investment security is confirmed through the company's sales history.

Key competitors